Amalgamated Financial’s Rallybio RLYB Stock Holding History

Amalgamated Financial’s Portfolio RLYB Stock Details RLYB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$7K	Buy	+133	New	+$11K	﹤0.01%	2940

Other funds holding RLYB

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

5VM

5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return

TGA

TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

CPX

Canaan Partners XI Menlo Park, California $127M AUM 217.49% 1-Year Est. Return

NLVP

New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return

PBPIA

Pivotal bioVenture Partners Investment Advisor San Francisco, California $280M AUM 181.4% 1-Year Est. Return

TCM

Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AIIC

AJU IB Investment Company Seoul, South Korea $30.5M AUM 128.96% 1-Year Est. Return

Amalgamated Financial's RLYB Position: Q1 2022 in Review

Amalgamated Financial opened a new position in Rallybio (RLYB) in Q1 2022: 133 shares worth $7K. The stake represents ﹤0.01% of the portfolio and ranks #2940 among its holdings.

47 funds tracked by Wall St. Rank hold RLYB as of Q1 2022.

Amalgamated Financial held 133 shares of Rallybio worth $7K as of Q1 2022.
Rallybio was a new Amalgamated Financial position in Q1 2022.
Rallybio made up ﹤0.01% of Amalgamated Financial's portfolio in Q1 2022, its #2940 holding.
47 funds tracked by Wall St. Rank held Rallybio as of Q1 2022.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.